Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0XG6U
|
||||
Former ID |
DIB020242
|
||||
Drug Name |
LSP1-2111
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [541839] | ||
Structure |
Download2D MOL |
||||
Formula |
C12H17N2O9P
|
||||
InChI |
InChI=1S/C12H17N2O9P/c1-23-9-5-6(4-8(10(9)15)14(19)20)12(18)24(21,22)3-2-7(13)11(16)17/h4-5,7,12,15,18H,2-3,13H2,1H3,(H,16,17)(H,21,22)/t7-,12?/m0/s1
|
||||
InChIKey |
PEXVMHLARUAHNC-KAJCPDDVSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Metabotropic glutamate receptor 7 | Target Info | Agonist | [530212] | |
Metabotropic glutamate receptor 4 | Target Info | Agonist | [530212] | ||
mGlu6 receptor | Target Info | Agonist | [530212] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Metabotropic glutamate receptor group III pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Metabotropic glutamate receptor group III pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.